Viewing Study NCT05350969


Ignite Creation Date: 2025-12-24 @ 10:56 PM
Ignite Modification Date: 2026-06-04 @ 8:58 PM
Study NCT ID: NCT05350969
Status: COMPLETED
Last Update Posted: 2025-07-03
First Post: 2022-04-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Assess Efficacy and Safety of CDR132L in Patients With Reduced Left Ventricular Ejection Fraction After Myocardial Infarction
Sponsor: Cardior Pharmaceuticals GmbH
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myocardial Infarction, Acute View
None Heart Failure, Left Sided View
Keywords: